A case of a Comél-Netherton syndrome patient treated with UVA1 phototherapy

Postepy Dermatologii i Alergologii

Volumn 28, Issue 5, 2011, Pages 418-421

  Osmola Mańkowska, Agnieszka ^a   Silny, Wojciech ^a   Dańczak Pazdrowska, Aleksandra ^a   Bowszyc Dmochowska, Monika ^a   Olek Hrab, Karolina ^a   Sadowska Przytocka, Anna ^a   Czarnecka Operacz, Magdalena ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Com l Netherton syndrome; Treatment; Uva1 phototherapy

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; EMOLLIENT AGENT; IMMUNOGLOBULIN E; RETINOID; STEROID;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; COMEL NETHERTON SYNDROME; DRUG WITHDRAWAL; FEMALE; GENODERMATOSIS; HAIR LOSS; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LABORATORY TEST; LEUKOPENIA; LYMPHOCYTOSIS; PATIENT SATISFACTION; PHOTOTHERAPY; PRICK TEST; RADIATION DOSE; RECURRENT DISEASE; SKIN BIOPSY; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION;

EID: 81255131846     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mevorach B, Frenk E, Brooke EM. Ichthiosis linearis circumflexa Comel. A clinico-statistical approach to its relationship with Netherton's syndrome. Dermatologica 1974; 149: 201-9.
2. Chavas S, Bodemer C, Rochat A, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Genetics 2000; 25: 141-2. (Pubitemid 30394980)
3. Kowalewski C. Skin barrier dysfunction as a risk factor for developement of allergic disorders. Post Dermatol Alergol 2009; 26: 342-3.
4. Oji V, Traupe H. Ichthyosis: clinical manifestations and practical treatment options. Am J Clin Dermatol 2009; 10: 351-64.
5. Komatsu N, Saijoh K, Jayakumar A, et al. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patents. J Invest Dermatol 2008; 128: 1148-59. (Pubitemid 351543199)
6. Lever WF, Schamburg-Lever G. Histopathology of the skin. Seventh edition. J.B. Lippincott Company, Philadelphia 1990.
7. Ackermann AB, Chongchitnant, Sanchez J, et al. Histologic diagnosis of inflamatory skin diseases: an algorythmic method based on pattern analysis. 2nd ed. Williams and Wilkins, Baltimore 1997.
8. Di WL, Larcher F, Semenova E, et al. Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome-derived skin grafts. Mol Ther 2011; 19: 408-16.
9. Halverstam CP, Vachharajani A, Mallory SB. Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome. Pediatr Dermatol 2007; 24: 42-5.
10. Allen A, Siegfried E, Silverman R, et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001; 137: 747-50. (Pubitemid 32577856)
11. Yan AC, Honig PJ, Ming ME, et al. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. Arch Dermatol 2010; 146: 57-62.
12. Silny W, Sadowska A, Dańczak-Pazdrowska A, Polańska A. Application of tacrolimus in the treatment of skin diseases other than atopic dermatitis. Post Dermatol Alergol 2011; 28: 41-5.
13. Hartschuh W, Hausner I, Petzoldt D. Successful retinoid therapy of Netherton syndrome. Hautarzt 1989; 40: 430-3. (Pubitemid 19175001)
14. Nagata T. Netherton's syndrome which responded to photochemotherapy. Dermatologica 1980; 161: 51-6. (Pubitemid 10156818)
15. Manabe M, Yoshiike T, Negi M, Ogawa H. Successful therapy of ichthyosis linearis circumflexa with PUVA. J Am Acad Dermatol 1983; 6: 905-7. (Pubitemid 13094715)
16. Gambichler T, Senger E, Altmeyer P, Hoffmann K. Clearence of ichthyosis linearis circumflexa with balneophototherapy. J Eur Acad Dermatol Venrol 2000; 14: 397-9. (Pubitemid 32898895)
17. Capezzera R, Venturini M, Bianchi D, et al. UVA1 phototherapy of Netherton syndrome. Acta Derm Venereol 2004; 84: 69-70.
18. Silny W, Osmola-Mańkowska A, Czarnecka-Operacz M, Szewczyk A. Narrow band UVA1 phototherapy in dermatological treatment: first polish experiences. Post Dermatol Alergol 2010; 27: 1-10.
19. Krutmann J, Czech W, Diepegen T, et al. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-30.
20. Zmudzka BZ, Olvey KM, Lee W, Beer JZ. Reassesment of the differencial effects of ultraviolet and ionizing radiation on HIV promoter: the use of cell survival as the bias for comparisons. J Photochem Photobiol 1996; 59: 643-9. (Pubitemid 2103376)